| 尿激酶治疗以偏瘫为主的急性脑梗塞160例疗效观察 |
| |
| 引用本文： | 吴祖舜,袁佩芳.尿激酶治疗以偏瘫为主的急性脑梗塞160例疗效观察[J].脑与神经疾病杂志,1998,6(4):216-218. |
| |
| 作者姓名： | 吴祖舜 袁佩芳 |
| |
| 作者单位： | 南京医科大学第二附属医院神经科 210011
(吴祖舜，袁佩芳，王小冬，高俊凤)，南京医科大学第二附属医院神经科 210011(冯美江) |
| |
| 摘 要： | 本文报告急性脑梗塞260例,其中160例急性脑梗塞应用尿激酶10万~U+N·S100ml,静脉滴注,q12h×10天;100例应用Svate-Ⅲ 2~U+N·S100ml,静脉滴注一次/日×15天,两组同时应用Ca~(++)拮抗剂,稀释疗法及脑细胞赋形剂治疗。结果尿激酶组基愈率为65%,显效率90.63%,总有效率达96.26%,非常显著优于Svate-Ⅲ的51%、75%及89%。结果提示尿激酶治疗急性脑梗塞在注意出血倾向发生时是安全、有效的。
|
| 关 键 词： | 尿激酶 急性脑梗塞 Svate-Ⅲ |
The Observation on Efficacy of Urokinasum (UK) in the Treatment of Cerebral Infarction With the Inital Ictal Moter Manifestions In 160 Patients |
| |
| Wu Zushun et al.The Observation on Efficacy of Urokinasum (UK) in the Treatment of Cerebral Infarction With the Inital Ictal Moter Manifestions In 160 Patients[J].Journal of Brain and Nervous Diseases,1998,6(4):216-218. |
| |
| Authors: | Wu Zushun |
| |
| Institution: | Wu Zushun et al
Department of Neurology,The 2nd Affiliated Hospital of Nanjing Medical University,210011 |
| |
| Abstract: | Urokinasum is a dissovle-emloli medicine, which can improve microcirculation. 160 patients with cerebral infarction in acute period treated were observed. Rate of striking effect and total improvement rate were 90. 63% and 96. 26% respectively. Compered with 100 patients controls with Svate- Ⅲ , which rate of striking effect and total improvement rate were 75% and 89% respectively. There were marked differences in striking effect rate and total improvement rate (P<0. 01). The data indicated that effect of this medicine was apparent, safe with little side-effects. UK is suitable for early use. |
| |
| Keywords: | Urokinsum Svate- Ⅲ Acute-infarction initial ictal moter menifestation Dissovle-emloli |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
